1. Pancreas. 2022 Nov-Dec 01;51(10):1359-1364. doi: 10.1097/MPA.0000000000002180.

Racial and Ethnic Disparities in Opioid Prescriptions in Benign and Malignant 
Pancreatic Disease in the United States.

McHenry N(1), Ahmed A(1), Shah I(1), Freedman SD(2), Nee J(1), Lembo A(1), Sheth 
SG(2).

Author information:
(1)From the Digestive Disease Center.
(2)Pancreas Center, Beth IsraelDeaconess Medical Center, Boston, MA.

OBJECTIVES: Racial-ethnic disparities in pain management are common but not 
known among pancreatic disease patients. We sought to evaluate racial-ethnic 
disparities in opioid prescriptions for pancreatitis and pancreatic cancer 
patients.
METHODS: Data from the National Ambulatory Medical Care Survey were used to 
examine racial-ethnic and sex differences in opioid prescriptions for ambulatory 
visits by adult pancreatic disease patients.
RESULTS: We identified 207 pancreatitis and 196 pancreatic cancer patient 
visits, representing 9.8 million visits, but weights were repealed for analysis. 
No sex differences in opioid prescriptions were found among pancreatitis (P = 
0.78) or pancreatic cancer patient visits (P = 0.57). Opioids were prescribed at 
58% of Black, 37% of White, and 19% of Hispanic pancreatitis patient visits (P = 
0.05). Opioid prescriptions were less common in Hispanic versus non-Hispanic 
pancreatitis patients (odds ratio, 0.35; 95% confidence interval, 0.14-0.91; P = 
0.03). We found no racial-ethnic differences in opioid prescriptions among 
pancreatic cancer patient visits.
CONCLUSIONS: Racial-ethnic disparities in opioid prescriptions were observed in 
pancreatitis, but not pancreatic cancer patient visits, suggesting possible 
racial-ethnic bias in opioid prescription practices for patients with benign 
pancreatic disease. However, there is a lower threshold for opioid provision in 
the treatment of malignant, terminal disease.

Copyright Â© 2023 Wolters Kluwer Health, Inc. All rights reserved.

DOI: 10.1097/MPA.0000000000002180
PMID: 37099779 [Indexed for MEDLINE]

Conflict of interest statement: The authors declare no conflict of interest.